Agenda
HCM9 offers a deep, integrated look at the evolving landscape of hypertrophic cardiomyopathy, bringing together leading experts for evidence-based lectures, practical case discussions, and interdisciplinary conversations.
Across four days and 50+ sessions, internationally recognized faculty will present the latest advances shaping HCM evaluation, treatment, and long-term patient care—relevant to all members of the care team continuum.
CineMed designates this Other Activity (Live & Enduring) for a maximum of 19.25 AMA PRA Category 1 Credit(s)™.
Agenda PDF
Downloadable, shareable, at-a-glance.
*Calling all nurses, NPs & PAs who are registered for HCM9: our Thursday night Care Team Forum is FREE — and designed exclusively for you. Join us!
Click preview to view/download.
Thursday
October 22, 2026
REGISTRATION
LOBBY / PLAZA LEVEL 3
3:00 PM
4:00 PM
INDUSTRY PRODUCT THEATER
SEAPORT BALLROOM / MEZZANINE LEVEL 2
Title: The Future of HCM Management: Emerging Data and Therapeutic Advances
Speaker: Mariko Harper, MD
5:30 PM
INDUSTRY PRODUCT THEATER
SEAPORT BALLROOM / MEZZANINE LEVEL 2
Title: Beyond the Gradient: Exploring the Potential of Dual SGLT1 & 2 Inhibition in the Treatment of HCM
Speaker: Sharlene Day, MD, PhD
HCM CARE TEAM FORUM: For PAs, NPs and Nurses
7:00 PM
- 8:30 PM
FLAGSHIP BALLROOM / MEZZANINE LEVEL 2
Co-Hosts: Anna Rodonski, PA-C & Catherine Carroll, NP-C
Sponsors: Cytokinetics, Bristol Myers Squibb, Edgewise Therapeutics, Lexicon Pharmaceuticals
IN-PERSON ONLY. REGISTERED HCM9 ATTENDEES ONLY.
PRE-REGISTRATION REQUIRED (VIA THE BUTTON ABOVE).